News

Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation
March 4, 2021
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms
Universal Definition and Classification of Heart Failure
March 3, 2021
The Heart Failure Society of America (HFSA), the Heart Failure Association of the European Society of Cardiology (HFA-ESC) and the Japanese Heart Failure Society (JHFS) announced a new Universal Definition and Classification of Heart Failure, which will standardize language and practices around the definition and classification of heart failure (HF).
Acutus Medical Receives Vizient Innovative Technology Contract
March 2, 2021
Contract Pricing Now Widely Available for the AcQMap® High Resolution 3D Imaging and Mapping System
New Analysis of REVERSE Trial Reveals Benefits of CRT for More Patients with Heart Failure
March 2, 2021
Findings highlight need to better classify heart failure outcomes
Maastricht University Medical Center Commences Procedures
February 25, 2021
Imricor Medical Systems, Inc. the global leader in MRI-guided cardiac ablation products, is pleased to announce the Maastricht University Medical Centre+ (MUMC+) in the Netherlands has commenced procedures since the extended lockdowns across Europe precluded elective surgeries. The team at MUMC+ successfully performed two atrial flutter ablations yesterday.
Image highlighting HeartLight X3’s direct visualization feature. Here we see a fully occluded pulmonary vein with stable and effective contact (white circumferential area). The endoscopic ablation systems laser is seen in green at 5 o’clock delivering a RAPID mode lesion set.
CardioFocus Announces the Publication of HeartLight X3 Pivotal Study Data
February 25, 2021
HeartLight® X3 System has significantly shorter procedure times for atrial fibrillation ablation
Home Heart Monitoring Effective for Detecting Irregular Heart Rhythm
February 24, 2021
A transatlantic study collaboration between researchers from Canada and Germany has demonstrated that a wearable heart monitor device can significantly improve the detection of atrial fibrillation, a major risk factor for stroke.
The world’s first ring-type heart monitoring device, CART-I developed by Sky Labs. The CART (Cardio Tracker)–I, a ring-type medical device monitors heart signals and detects diseases by using optical sensors. The photoplethysmography (PPG) sensor in the ring monitors the bloodstream in the finger and continuously measures the irregular pulse waves of atrial fibrillation. Electrocardiogram (ECG) can also be measured by simply placing the fingers on the metal part of the ring. Sky Labs provided its CART-I for
Sky Labs CART-I Invited to a Clinical Study at Oxford University
February 22, 2021
A smart-alert study to guide anticoagulant treatment for patients with atrial fibrillation
RhythMedix Launches Next-Generation RhythmStar® Device, the First and Only Wearable Cardiac Monitor with Built-In Cellular Connectivity
February 22, 2021
RhythMedix, a leader in remote cardiac monitoring, announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity.
Swiss-based MedTech Startup EBAMed Appoints Marina Izzo as CEO
February 18, 2021
EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022.